# EMPAGLIFLOZIN
> **NDA220758** · New Drug Application · Sponsor: RIDHISIDHI, PLLC · Approved 2026-09-17
## Drug
- **FDA Application Number:** NDA220758
- **Application type:** New Drug Application
- **Brand name:** EMPAGLIFLOZIN
- **Generic name:** Empagliflozin
- **Active ingredients:** EMPAGLIFLOZIN
- **Dosage form:** SOLUTION
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** RIDHISIDHI, PLLC
- **First approval:** 2026-09-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220758)
---
*MORVS · CC0 1.0*